Welcome to our dedicated page for HEALTHCARE SERVICES GROUP SEC filings (Ticker: HCSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HEALTHCARE SERVICES GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HEALTHCARE SERVICES GROUP's regulatory disclosures and financial reporting.
Healthcare Services Group Inc. executive Patrick J. Orr, EVP & Chief Revenue Officer, reported multiple stock option exercises and a share sale. On February 18, 2026, he exercised several stock option grants, lifting his direct common stock holdings to 90,115 shares before selling 45,500 shares in an open-market transaction at $20.54 per share, ending with 44,615 shares held directly.
Healthcare Services Group Inc EVP & Chief Admin. Officer John Christopher Shea reported multiple equity transactions in company stock. On February 18, 2026, he exercised stock options for 29,579 shares at $18.10 and 9,278 shares at $13.72, converting them into common stock. The filing also shows open-market sales of 15,500 common shares at $20.52 and 38,857 common shares at $20.36. Following these exercises and sales, his directly held common stock position is reported as 29,292 shares.
HEALTHCARE SERVICES GROUP INC President & CEO Theodore Wahl reported routine equity compensation activity in company common stock. On February 17, 2026, he acquired 8,511 shares at $20.93 per share as a grant under the annual incentive program, then disposed of 8,511 shares at $20.93 per share to cover related tax obligations through share withholding, a non‑open‑market transaction. After these transactions, directly held common stock was reported as 486,863 shares, and a footnote states total direct and indirect beneficial ownership of 604,210 shares.
HCSG executive files a Form 144 to sell common stock through Morgan Stanley Smith Barney LLC. The filing lists four blocks of common shares associated with different award types: 31,826 (restricted stock, 01/04/2019), 11,167 (employee stock purchase plan, 12/31/2017), 45,500 (stock option exercise, 02/18/2026), and 1,623 (performance shares, 02/24/2025).
Morgan Stanley Smith Barney LLC submitted a Form 144 notice to sell shares of HCSG. The filing lists multiple restricted stock grant lots by grant date and a stock option exercise of 38,857 shares dated 02/18/2026. The entries are listed as issuer-originated restricted awards and a cash exercise.
Mackenzie Financial Corporation reports beneficial ownership of 3,549,789 common shares of Healthcare Services Group Inc., representing 5.04% of the outstanding class. Mackenzie has sole power to vote and dispose of these shares, with no shared voting or dispositive power.
The ownership is reported on an amended Schedule 13G, filed as Amendment No. 11, with the reportable event dated 12/31/2025. Mackenzie states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.
Healthcare Services Group, Inc. reports 2025 results showing moderate growth with rising credit risk. Revenue increased 7.1% to $1,837.2 million, with Environmental Services contributing $824.7 million and Dietary $1,012.5 million. Net income rose 49.6% to $59.1 million, lifting net margin to 3.2%.
Profitability was helped by $34.2 million of Employee Retention Credit refunds and $5.3 million of related interest income. At the same time, credit issues intensified: bad debt provisions increased to $83.1 million, or 4.5% of revenue, including $63.9 million tied to Genesis Healthcare’s Chapter 11 bankruptcy, a customer that represented 7.3% of 2025 revenue.
The company served about 2,800 facilities at year-end, with labor and supply costs remaining the largest expense drivers across both segments. Management highlights ongoing inflation, tariff exposure, labor market pressures, customer financial health, cybersecurity risks and evolving healthcare and tax regulations as key risk factors for future results.
Healthcare Services Group, Inc. reported solid 2025 growth and boosted capital returns while outlining 2026 targets. Full-year revenue reached $1.84 billion, up 7.1%, with fourth-quarter revenue of $466.7 million, a 6.6% increase. Net income rose to $59.1 million for 2025 and $31.2 million in the fourth quarter, with diluted EPS of $0.81 for the year and $0.44 for the quarter.
Cash flow from operations was $145.0 million for 2025, or $164.1 million excluding payroll accrual changes. The company completed a $50.0 million buyback in 2025 and its board authorized repurchases of up to 10.0 million shares, with plans to repurchase $75.0 million of stock over 12 months. Management expects mid-single-digit revenue growth and targets 2026 cost of services in the 86% range and SG&A between 9.5% and 10.5%. Year-end liquidity included $203.9 million of cash and marketable securities plus an unused $300.0 million credit facility.
Healthcare Services Group, Inc. (HCSG) President & CEO Theodore Wahl reported multiple equity transactions in common stock, restricted stock units (RSUs) and phantom stock. On December 31, 2025, he acquired 2,145 shares of common stock at $9.88 through the company’s Employee Stock Purchase Plan and 2,788 shares of phantom stock at $19.12 under a deferred compensation plan, with phantom stock payable in kind after his employment ends.
On January 3 and 4, 2026, several RSU awards were converted into common stock at a 1-for-1 rate, increasing his directly held common shares and reducing the related RSU balances, followed by a disposition of 35,450 common shares coded “F.” On January 5, 2026, he received a new grant of 93,693 RSUs at $0, which will vest 20% annually beginning on the first anniversary of the grant date. After these transactions, total direct and indirect beneficial ownership is reported as 604,211 shares.
Healthcare Services Group, Inc. EVP & Chief Operating Officer Andrew Kush reported multiple equity transactions in early January 2026. On January 3, 2026, several blocks of Restricted Stock Units (RSUs) converted into a total of 6,245 and 5,785 shares of common stock at an exercise price of $0, leaving him with 30,423 and then 36,208 common shares directly owned after those conversions.
On January 4, 2026, additional RSUs converted into 2,002 and 3,317 common shares at $0, with direct common stock holdings of 20,861 and then 24,178 shares reported after those moves. On January 5, 2026, a disposition of 7,676 common shares coded "F" left him with 28,532 directly owned common shares.
Separately, Kush received 1,628 shares of phantom stock on December 31, 2025 under the deferred compensation plan, bringing phantom stock to 16,452 units. He was also granted 20,060 new RSUs on January 5, 2026, with a 1-for-1 share conversion rate and 20% annual vesting starting on the first anniversary of that grant date.